PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
18.95%
Net income growth at 75-90% of ORCL's 24.39%. Bill Ackman would call for strategic or operational tweaks to match competitor’s earnings growth.
-4.40%
Both reduce yoy D&A, with ORCL at -8.97%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-36.18%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-232.16%
Negative yoy working capital usage while ORCL is 91.24%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-232.16%
Negative yoy usage while ORCL is 91.24%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
211.73%
Well above ORCL's 12.13%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-3.07%
Negative yoy CFO while ORCL is 169.58%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-11.02%
Both yoy lines negative, with ORCL at -9.81%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
7.08%
Less growth in investment purchases vs. ORCL's 100.00%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
27.15%
We have some liquidation growth while ORCL is negative at -57.03%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
93.19%
We have mild expansions while ORCL is negative at -116.99%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-46.93%
Negative yoy issuance while ORCL is 62.70%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-7.19%
We cut yoy buybacks while ORCL is 28.57%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.